Plasma levels of interleukin-8 and expression of interleukin-8 receptors on circulating neutrophils and monocytes after cardiopulmonary bypass in children

Journal of Thoracic and Cardiovascular Surgery

Volumn 126, Issue 3, 2003, Pages 718-725

  Gessler, Peter ^a   Pfenninger, Juerg ^b   Pfammatter, Jean Pierre ^b   Carrel, Thierry ^c   Baenziger, Oskar ^a   Dahinden, Clemens ^d  

^a UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

^b UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

^c BERN UNIVERSITY HOSPITAL   (Switzerland)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

CD14 ANTIGEN; CHEMOKINE RECEPTOR CXCR1; CHEMOKINE RECEPTOR CXCR2; INTERLEUKIN 6; INTERLEUKIN 8; INTERLEUKIN 8 RECEPTOR; MYELOPEROXIDASE; NITRIC OXIDE;

ARTERIAL OXYGEN TENSION; ARTICLE; ARTIFICIAL VENTILATION; CARDIOPULMONARY BYPASS; CELL STIMULATION; CHILD; CLINICAL ARTICLE; CORRELATION ANALYSIS; FLOW CYTOMETRY; HUMAN; IMMUNOASSAY; INFANT; INFLAMMATION; INOTROPISM; MONOCYTE; NEUTROPHIL; PEDIATRIC SURGERY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION;

EID: 0141606836     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5223(03)00685-8     Document Type: Article

References (47)

1. Paparella D, Yau TM, Young E. Cardiopulmonary bypass induced inflammation: pathophysiology and treatment. An update. Eur J Cardiothorac Surg. 2002;21:232-4.
2. Hill GE. Cardiopulmonary bypass-induced inflammation: is it important? J Cardiothorac Vasc Anesth. 1998;12(Suppl 1):21-5.
3. Cremer J, Martin M, Redl H, et al. Systemic inflammatory response syndrome after cardiac operations. Ann Thorac Surg. 1996;61:1714-20.
4. Frering B, Philip I, Dehoux M, Rolland C, Langlois JM, Desmonts JM. Circulating cytokines in patients undergoing normothermic cardiopulmonary bypass. J Thorac Cardiovasc Surg. 1994;108:636-41.
5. Dehoux MS, Hernot S, Asehnoune K, et al. Cardiopulmonary bypass decreases cytokine production in lipopolysaccharide-stimulated whole blood cells: roles of interleukin-10 and the extracorporeal circuit. Crit Care Med. 2000;28:1721-7.
6. Frangogiannis NG, Mendoza LH, Lindsey ML, et al. IL-10 is induced in the reperfused myocardium and may modulate the reaction to injury. J Immunol. 2000;165:2798-808.
7. Tarnok A, Schneider P. Pediatric cardiac surgery with cardiopulmonary bypass: pathways contributing to transient systemic immune suppression. Shock. 2001:16(Suppl 1):24-32.
8. Moncada S, Higgs A. The L-arginine-nitric oxide pathway. N Engl J Med. 1993;329:2002-12.
9. Hayashi Y, Sawa Y, Fukuyama N, Nakazawa H, Matsuda H. Inducible nitric oxide production is an adaptation to cardiopulmonary bypass-induced inflammatory response. Ann Thorac Surg. 2001;72:149-55.
10. Ruvolo G, Greco E, Speziale G, et al. Nitric oxide formation during cardiopulmonary bypass. Ann Thorac Surg. 1994;57:1055-7.
11. Finkel MS, Oddis CV, Jacob TD, Watkins SC, Hattler BG, Simmons RL. Negative inotropic effects of cytokines on the heart mediated by nitric oxide. Science. 1992;257:387-9.
12. Kubes P, Suzuki M, Granger DN. Nitric oxide: an endogenous modulator of leukocyte adhesion. Proc Natl Acad Sci U S A. 1991;88: 4651-5.
13. Niu X, Smith CW, Kubes P. Intercellular oxidative stress induced by nitric oxide synthesis inhibition increases endothelial cell adhesion to neutrophil. Circ Res. 1994;74:1133-40.
14. Weiss SJ. Tissue destruction by neutrophils. N Engl J Med. 1989;320: 365-76.
15. Delves PJ, Rosen FS. The immune system. N Engl J Med. 2000;343: 37-49.
16. Luster AD. Chemokines-chemotactic cytokines that mediate inflammation. N Engl J Med. 1998;338:436-45.
17. Baggiolini M, Dewald B, Moser B. Interleukin-8 and related chemotactic cytokines-CXC and CC chemokines. Adv Immunol. 1994;55:97-179.
18. Ivey CL, Williams FM, Collins PD, Jose PJ, Williams TJ. Neutrophil chemoattractants generated in 2 phases during reperfusion of ischemic myocardium in the rabbit. Evidence for a role for C5a and interleukin-8. J Clin Invest. 1995;95:2720-8.
19. Kukielka GL, Smith CW, LaRosa GJ, et al. Interleukin-8 gene induction in the myocardium after ischemia and reperfusion in vivo. J Clin Invest. 1995;95:89-103.
20. Holmes WE, Lee J, Kuang WJ, Rice GC, Wood WI. Structure and functional expression of a human interleukin-8 receptor. Science. 1991;253:1278-80.
21. Murphy PM, Tiffany HL. Cloning of complementary DNA encoding a functional human interleukin-8 receptor. Science. 1991;253:1280-3.
22. Moser B, Barella L, Mattei S, et al. Expression of transcripts for two interleukin 8 receptors in human phagocytes, lymphocytes and melanoma cells. Biochem J. 1993;294:285-92.
23. Lequier LL, Nikaidoh H, Leonard SR, et al. Preoperative and postoperative endotoxemia in children with congenital heart disease. Chest. 2000;117:1706-12.
24. Khabar KS, elBarbary MA, Khouqeer F, Devol E, al-Gain S, al-Halees Z. Circulating endotoxin and cytokines after cardiopulmonary bypass: differential correlation with duration of bypass and systemic inflammatory response/multiple organ dysfunction syndromes. Clin Immunol Immunopathol. 1997;85:97-103.
25. Van Snick J. Interleukin-6: an overview. Annu Rev. Immunol. 1990;8: 253-78.
26. Plenz G, Song ZF, Reichenberg S, Tjan TD, Robeneck H, Deng MC. Left-ventricular expression of interleukin-6 messenger-RNA higher in idiopathic dilated than in ischemic cardiomyopathy. Thorac Cardiovasc Surg. 1998;46:213-6.
27. Burger A. Benicke M, Deten A, Zimmer HG. Catecholamines stimulate interleukin-6 synthesis in rat cardiac fibroblasts. Am J Physiol Heart Circ Physiol. 2001;281:H14-21.
28. Simmons DL, Tan S, Tenen DG, Nicholson-Weller A, Seed B. Monocyte antigen CD14 is a phospholipid anchored membrane protein. Blood. 1989;73:284-9.
29. Wright SD, Ramos RA. Tobias PS, Ulevitch RJ, Mathison JC. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science. 1990;249:1431-3.
30. Weidemann B, Brade H, Rietschel ET, et al. Soluble peptidoglycan-induced monokine production can be blocked by anti-CD14 monoclonal antibodies and by lipid A partial structures. Infect Immun. 1994; 62:4709-15.
31. Heidenreich S, Schmidt M, August C, Cullen P, Rademaekers A, Pauels HG. Regulation of human monocyte apoptosis by the CD14 molecule. J Immunol. 1997;159:3178-88.
32. Devitt A, Moffatt OD, Raykundalia C, Capra JD, Simmons DL, Gregory CD. Human CD14 mediates recognition and phagocytosis of apoptotic cells. Nature. 1998;392:505-9.
33. Schütt C. CD14. Int J Biochem Cell Biol. 1999;31:545-9.
34. Landmann R, Ludwig C, Obrist R, Obrecht JP. Effect of cytokines and lipopolysaccharide on CD14 antigen expression in human monocytes and macrophages. J Cell Biochem. 1991;47:317-29.
35. Marchant A, Duchow J, Delville JP, Goldman M. Lipopolysaccharide induces up-regulation of CD14 molecules on monocytes in human whole blood. Eur J Immunol. 1992:22:1663-5.
36. Butler J, Rocker GM, Westaby S. Inflammatory response to cardiopulmonary bypass. Ann Thorac Surg. 1994;58:1567-8.
37. Mathie RT, Ohri SK, Keogh BE, Williams J, Siney L, Griffith TM. Nitric oxide activity in patients undergoing cardiopulmonary bypass. J Thorac Cardiovasc Surg. 1996;112:1394-5.
38. Kishimoto T, Akira S, Taga T. Interleukin-6 and its receptor: a paradigm for cytokines. Science. 1992;258:593-7.
39. Janssens SP, Shimouchi A, Quertermous T, Bloch DB, Bloch KD. Cloning and expression of a cDNA encoding human endothelium-derived relaxing factor/nitric oxide synthase. J Biol Chem. 1992;267: 14519-22.
40. Waldman SA, Murad F. Biochemical mechanisms underlying vascular smooth muscle relaxation: the guanylate cyclase-cyclic GMP system. J Cardiovasc Pharmacol. 1988;12(Suppl 5):S115-8.
41. Gaboury JP, Anderson DC, Kubes P. Molecular mechanisms involved in superoxide-induced leukocyte-endothelial cell interactions in vivo. Am J Physiol. 1994;266:H637-42.
42. Peveri P, Walz A, Dewald B, Baggioloni M. A novel neutrophil-activating factor produced by human mononuclear phagocytes. J Exp Med. 1988;167:1547-59.
43. Samanta AK, Oppenheim JJ, Matsushima K. Interleukin-8 (monocyte-derived neutrophil chemotactic factor) dynamically regulates its own receptor expression on human neutrophils. J Biol Chem. 1990;265: 183-9.
44. Chuntharapai A, Kim KJ. Regulation of the expression of IL-8 receptor A/ B by IL-8: possible functions of each receptor. J Immunol. 1995;155:2587-94.
45. Baggiolini M. Chemokines and leukocyte traffic. Nature. 1998;392: 565-8.
46. Sabroe I, Timothy JW, Hebert CA, Collins PD. Chemoattractant cross-desensitization of the human neutrophil IL-8 receptor involves receptor internalization and differential receptor subtype regulation. J Immunol. 1997; 158:1361-9.
47. White JR, Lee JM, Young PR, et al. Identification of a potent, selective non-peptide CXCR2 antagonist that inhibits interleukin-8 induced neutrophil migration. J Biol Chem. 1998;273:10095-8.